A.A. Verstraeten

1.6k total citations
31 papers, 1.3k citations indexed

About

A.A. Verstraeten is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, A.A. Verstraeten has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Genetics. Recurrent topics in A.A. Verstraeten's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). A.A. Verstraeten is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). A.A. Verstraeten collaborates with scholars based in Netherlands, Germany and United Kingdom. A.A. Verstraeten's co-authors include Peter Kenemans, Silvia von Mensdorff‐Pouilly, Gerard J. van Kamp, R. Van Nie, F.G.M. Snijdewint, J. Hilgers, Jo Hilgers, Sybren L. Meijer, H. G. Kwa and S. V. Litvinov and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and British Journal of Cancer.

In The Last Decade

A.A. Verstraeten

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.A. Verstraeten Netherlands 20 590 402 371 279 205 31 1.3k
R. Verheijen Netherlands 17 433 0.7× 185 0.5× 166 0.4× 203 0.7× 132 0.6× 29 1.1k
Ronald Peek Netherlands 18 460 0.8× 185 0.5× 133 0.4× 104 0.4× 277 1.4× 42 1.2k
DA Williams United States 16 575 1.0× 599 1.5× 84 0.2× 444 1.6× 46 0.2× 37 1.5k
Hong Zhan United Kingdom 22 524 0.9× 520 1.3× 113 0.3× 519 1.9× 190 0.9× 53 1.7k
Marco A. Arap Brazil 17 660 1.1× 151 0.4× 250 0.7× 162 0.6× 57 0.3× 60 1.4k
Wendy K. Nevala United States 23 624 1.1× 810 2.0× 65 0.2× 705 2.5× 46 0.2× 67 1.8k
G. E. Moore United States 18 336 0.6× 223 0.6× 104 0.3× 258 0.9× 40 0.2× 51 882
Claudia Semino Italy 20 406 0.7× 803 2.0× 49 0.1× 295 1.1× 119 0.6× 51 1.4k
Christoph Müller Switzerland 17 339 0.6× 784 2.0× 33 0.1× 243 0.9× 54 0.3× 30 1.3k
Roger A. Reichert United States 13 263 0.4× 685 1.7× 293 0.8× 121 0.4× 20 0.1× 14 1.1k

Countries citing papers authored by A.A. Verstraeten

Since Specialization
Citations

This map shows the geographic impact of A.A. Verstraeten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.A. Verstraeten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.A. Verstraeten more than expected).

Fields of papers citing papers by A.A. Verstraeten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.A. Verstraeten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.A. Verstraeten. The network helps show where A.A. Verstraeten may publish in the future.

Co-authorship network of co-authors of A.A. Verstraeten

This figure shows the co-authorship network connecting the top 25 collaborators of A.A. Verstraeten. A scholar is included among the top collaborators of A.A. Verstraeten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.A. Verstraeten. A.A. Verstraeten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bakker, Petra, et al.. (2004). The quality of intrapartum fetal heart rate monitoring. European Journal of Obstetrics & Gynecology and Reproductive Biology. 116(1). 22–27. 52 indexed citations
2.
Bakker, Petra, et al.. (2004). Quality of intrapartum cardiotocography in twin deliveries. American Journal of Obstetrics and Gynecology. 191(6). 2114–2119. 6 indexed citations
3.
Kenemans, Peter, et al.. (2001). Maternal Serum CA125 and CA15-3 Antigen Levels in Normal and Pathological Pregnancy. Fetal Diagnosis and Therapy. 16(3). 166–172. 51 indexed citations
4.
Snijdewint, F.G.M., Silvia von Mensdorff‐Pouilly, A.A. Verstraeten, et al.. (1999). Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls. Cancer Immunology Immunotherapy. 48(1). 47–55. 31 indexed citations
5.
6.
Mensdorff‐Pouilly, Silvia von, Peter Kenemans, A.A. Verstraeten, et al.. (1996). Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. European Journal of Cancer. 32(8). 1325–1331. 108 indexed citations
7.
Hilgers, Jo, Silvia von Mensdorff‐Pouilly, A.A. Verstraeten, & Peter Kenemans. (1995). Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologists. Scandinavian Journal of Clinical and Laboratory Investigation. 55(sup221). 81–86. 10 indexed citations
8.
Kenemans, Peter, A.A. Verstraeten, Gerard J. van Kamp, & Silvia von Mensdorff‐Pouilly. (1995). The Second Generation CA125 Assays. Annals of Medicine. 27(1). 107–113. 26 indexed citations
9.
Mensdorff‐Pouilly, Silvia von, S. V. Litvinov, Peter Kenemans, et al.. (1995). Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. British Journal of Cancer. 72(4). 934–938. 91 indexed citations
10.
Steijlen, Peter M., et al.. (1994). Expression of tenascin, biglycan and decorin in disorders of keratinization. British Journal of Dermatology. 130(5). 564–568. 9 indexed citations
11.
Vlijmen‐Willems, Ivonne M.J.J. van, et al.. (1993). Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding). Journal of Dermatological Science. 5(1). 54–57. 8 indexed citations
12.
Kamp, Gerard J. van, A.A. Verstraeten, & Peter Kenemans. (1993). Discordant serum CA 125 values in commercial immunoassays. European Journal of Obstetrics & Gynecology and Reproductive Biology. 49(1-2). 99–103. 12 indexed citations
13.
Kenemans, Peter, Feja J. Voorhorst, L.V.A.M. Beex, et al.. (1993). CA 125 half-life in ovarian cancer: a multivariate survival analysis. British Journal of Cancer. 67(6). 1361–1367. 49 indexed citations
14.
Kenemans, Peter, Th. Wobbes, C.M.G. Thomas, et al.. (1992). Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal Adenocarcinomas. Tumor Biology. 13(1-2). 18–26. 51 indexed citations
15.
Verstraeten, A.A., et al.. (1992). Tenascin expression in basal cell carcinoma. British Journal of Dermatology. 127(6). 571–574. 38 indexed citations
16.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1988). The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. European Journal of Cancer and Clinical Oncology. 24(7). 1225–1231. 63 indexed citations
17.
Wang, D.Y., Bianca De Stavola, R.D. Bulbrook, et al.. (1987). The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. European Journal of Cancer and Clinical Oncology. 23(10). 1541–1548. 43 indexed citations
18.
L’Hermite, M., et al.. (1979). Term labor induction by prostaglandin (PG) E2 oral administration prior to amniotomy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 9(1). 29–33. 1 indexed citations
19.
Verstraeten, A.A., R. Van Nie, H. G. Kwa, & Ph. Hageman. (1975). Quantitative estimation of mouse mammary tumor virus (MTV) antigens by radioimmunoassay. International Journal of Cancer. 15(2). 270–281. 27 indexed citations
20.
Verstraeten, A.A., Ph. Hageman, & H. G. Kwa. (1973). A radioimmunoassay for MTV-antigens. European Journal of Cancer (1965). 9(2). 155–157. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Verheijen Breakdown of academic impact, for papers by Ronald Peek Breakdown of academic impact, for papers by DA Williams Breakdown of academic impact, for papers by Hong Zhan Breakdown of academic impact, for papers by Marco A. Arap Breakdown of academic impact, for papers by Wendy K. Nevala Breakdown of academic impact, for papers by G. E. Moore Breakdown of academic impact, for papers by Claudia Semino Breakdown of academic impact, for papers by Christoph Müller Breakdown of academic impact, for papers by Roger A. Reichert
Rankless by CCL
2026